COMPASS THERAPEUTICS, INC.

Insiders Compass Therapeutics, Inc.

Equities

CMPX

US20454B1044

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
1.7 ^USD	+3.03%		+17.24%	+8.97%

Apr. 25	Compass Therapeutics Gets FDA Fast-Track Designation for Biliary Tract Cancer Treatment	MT
Apr. 25	Compass Therapeutics Gets FDA Fast-Track for Cancer Treatment	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Compass Therapeutics, Inc. Announces Executive Changes, Effective January 9, 2024	Jan. 05	CI
Compass Therapeutics, Inc. Announces Chief Executive Officer Changes, Effective January 9, 2024	Jan. 05	CI
Ankyra Therapeutics Names Robert V. Tighe as Chief Scientific Officer	23-08-15	CI
Compass Therapeutics, Inc. Appoints Richard S. Lindahl as Class III Director, Member and Chairman of the Audit Committee	23-04-24	CI
Compass Therapeutics, Inc. Announces Resignation of David Wurzer to Board of Directors and Committees	23-02-24	CI
Compass Therapeutics, Inc. Appoints David Wurzer as Class III Director, Member and Chairman of the Audit Committee	23-02-10	CI
Susan Kalled, Departs Her Position as Chief Scientific Officer of Compass Therapeutics, Inc	22-11-29	CI
Compass Therapeutics, Inc. Appoints James P. Boylan as Class II Director	22-11-02	CI
Compass Therapeutics, Inc. Announces Resignation of Stephen Squinto as Member of the Board of Directors, Effective August 31, 2022	22-08-19	CI
Compass Therapeutics Announces Management Appointments	22-04-26	CI
Compass Therapeutics, Inc. Announces Resignation of Brett Kaplan of the Board of Directors	22-02-25	CI
Compass Therapeutics, Inc. Announces Resignation of Julie Sunderland Member of the Board of Directors, Effective December 31, 2021	21-12-21	CI
Insider Buy: Compass Therapeutics	21-11-09	MT
Compass Therapeutics Announces Executive Appointments	18-12-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer